Manuscripts submitted to the journals under e-current science are initially reviewed by the Managing Editor, who determines whether the manuscript meets the requirements of the journal and is worth sending out for thorough review. If so, then it is sent out to a reviewer who is experts in relevant fields, as selected by the Editor or Editor-in-Chief for review in a double blind process. This peer review process is designed to assure that e-current science journals publishes only original, accurate articles and essays that contribute to knowledge in the field of pharmaceutical science.
Reviewers are asked to assess submissions based on depth of original research, accuracy, appropriate documentation, readability, and suitability of content. Questions addressed include:
Reviewers are subjected for Blind Peer Review of the submitted article.
Reviewers make one of four recommendations: acceptance, provisional acceptance with revision or rejection. Reviewers are asked to include comments explaining the recommendation. Approximately 67 percent of submitted manuscripts are accepted for publication.
Authors receive the reviewers’ comments and are often asked to revise the manuscript in line with the reviewers’ and/or editor’s suggestions. If the revised article is accepted for publication, the editor then determines the journal issue in which it will appear. Accepted articles will usually appear in the next issue of the journal or within three months.